News from the FDA/CDC
News from the FDA/CDC
Busiest week yet brings 2019 measles total to 555 cases
United States is quickly closing in on a postelimination-era record.
News from the FDA/CDC
Large measles outbreak reported in Michigan
Commentary
Powerful breast-implant testimony constrained by limited evidence
SILVER SPRING, MD. – Women report personal horror stories of apparent breast-implant complications, but systematically-collected data remain...
News from the FDA/CDC
Measles: Latest weekly count is the highest of the year
New outbreaks are occurring in California and New Jersey, with a state of emergency declared in one New York county.
Conference Coverage
FDA panel calls for changes to breast implant rupture screening
The advisory panel seemed the current implant screening recommendation using MRI “useless.” They urged the adoption of ultrasound as a more...
News from the FDA/CDC
United States now over 300 measles cases for the year
Outbreak in Brooklyn accounted for half of last week’s new cases.
News from the FDA/CDC
Measles cases confirmed in three more states
News from the FDA/CDC
U.S. measles cases up to 159 for the year
News from the FDA/CDC
FDA: Safety signal emerged with higher dose of tofacitinib in RA study
The FDA is working with Pfizer to better understand how the signal affects patients and how the drug should be used, the agency said in a...
News
FDA: 246 new reports on breast implant-associated lymphoma
The latest update from the Food and Drug Administration includes medical device reports between September 2017 and September 2018.
Latest News
IPH4102 on fast track for Sézary syndrome
The designation is based on results from a phase 1 trial of 35 patients.